Amer Bio Medica Buy Hold or Sell Recommendation

ABMCDelisted Stock  USD 0.01  0  38.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Amer Bio Medica is 'Not Rated'. Macroaxis provides Amer Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amer Bio positions. The advice algorithm takes into account all of Amer Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Amer Bio's buy or sell advice are summarized below:
Real Value
0.0114
Hype Value
0.01
Market Value
0.0138
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Amer Bio Medica given historical horizon and risk tolerance towards Amer Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Amer Bio Medica, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
In addition, we conduct extensive research on individual companies such as Amer and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Amer Bio Medica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Execute Amer Bio Buy or Sell Advice

The Amer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Amer Bio Medica. Macroaxis does not own or have any residual interests in Amer Bio Medica or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Amer Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Amer BioBuy Amer Bio
Not Rated
For the selected time horizon Amer Bio Medica has a Risk Adjusted Performance of 0.0822, Jensen Alpha of 3.05, Total Risk Alpha of 0.534 and Treynor Ratio of (0.79)
We provide trade advice to complement the prevailing expert consensus on Amer Bio Medica. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Amer Bio is not overpriced, please confirm all Amer Bio Medica fundamentals, including its shares outstanding, gross profit, current ratio, as well as the relationship between the price to earning and cash and equivalents . As Amer Bio Medica appears to be a penny stock we also recommend to validate its price to earning numbers.

Amer Bio Trading Alerts and Improvement Suggestions

Amer Bio Medica is not yet fully synchronised with the market data
Amer Bio Medica has some characteristics of a very speculative penny stock
Amer Bio Medica has a very high chance of going through financial distress in the upcoming years
The company currently holds 1.53 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Amer Bio Medica has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amer Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Bio Medica sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Bio's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 2.22 M. Net Loss for the year was (463 K) with profit before overhead, payroll, taxes, and interest of 548 K.
Amer Bio Medica currently holds about 2 K in cash with (673 K) of positive cash flow from operations.
Roughly 31.0% of Amer Bio shares are held by company insiders

Amer Bio Returns Distribution Density

The distribution of Amer Bio's historical returns is an attempt to chart the uncertainty of Amer Bio's future price movements. The chart of the probability distribution of Amer Bio daily returns describes the distribution of returns around its average expected value. We use Amer Bio Medica price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Amer Bio returns is essential to provide solid investment advice for Amer Bio.
Mean Return
2.85
Value At Risk
0.00
Potential Upside
38.00
Standard Deviation
24.31
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Amer Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Amer Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Amer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Amer Bio Buy or Sell Advice

When is the right time to buy or sell Amer Bio Medica? Buying financial instruments such as Amer Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Amer Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sovereign ETFs Thematic Idea Now

Sovereign ETFs
Sovereign ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Amer Pink Sheet

If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets